• Info
  • Insider Ownership

Insider Trading & Ownership of Silberman David

Location
Jerusalem, Israel
Summary
The estimated net worth of Silberman David is at least $872,800 dollars as of 27 Mar 2026. Silberman David is the Chief Financial Officer of ORAMED PHARMACEUTICALS INC. and owns shares of ORAMED PHARMACEUTICALS INC. (ORMP) stock worth about $810K. Silberman David is the Chief Financial Officer of COMPUGEN LTD and owns shares of COMPUGEN LTD (CGEN) stock worth about $62.8K.
Signature
/s/ Silberman David
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Silberman David and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Silberman David has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $872,800.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ORAMED PHARMACEUTICALS INC. ($809,965).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Silberman David

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ORMP ORAMED PHARMACEUTICALS INC. Chief Financial Officer $809,965 04 Jan 2024
CGEN COMPUGEN LTD Chief Financial Officer $62,835 18 Mar 2026
NSRX Nasus Pharma Ltd Director 18 Mar 2026

Insider Transactions Reported by Silberman David:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored